Skip to main content
. 2023 Sep 8;14:5529. doi: 10.1038/s41467-023-41066-3

Fig. 7. FMD exerts cardio-protection against immunotherapy side effects via attenuating Reactive Oxygen Species (ROS), NLRP-3 inflammasome, leukotrienes and NF-kB expression in heart.

Fig. 7

ROS, NLRP-3 inflammasome, leukotrienes and NF-kB expression in heart (A) and plasma (B) (n = 5). Statistical analysis was performed using one-way analysis of variance (ANOVA). Differences were considered significant when P < 0.05. All data are represented as mean ± SEM. Source data are provided as a Source Data file.